NEWMarkets

Eli Lilly (LLY) GLP-1 Pill Approved: Launching Foundayo for Weight Loss

Published on 4/1/2026

#LLY#FDA#pharmaceuticals#weightloss#drugs
Eli Lilly (LLY) GLP-1 Pill Approved: Launching Foundayo for Weight Loss

AI Summary

Eli Lilly's (LLY) GLP-1 pill, Foundayo, has received FDA approval and will begin shipping via LillyDirect, available in pharmacies

Source: Read original article (opens in new tab)

Related News

Vivani Medical (VANI) Price Target Lowered to $3.50 from $4
Markets

Vivani Medical (VANI) Price Target Lowered to $3.50 from $4

Apr 1

Prosperity Bancshares (PB) Reports Q4 Performance Data and Insights
Markets

Prosperity Bancshares (PB) Reports Q4 Performance Data and Insights

Apr 1

NEWMONT Corp (NEM) Form 144 Filing on April 1, 2023
Markets

NEWMONT Corp (NEM) Form 144 Filing on April 1, 2023

Apr 1

Lilly (LLY) Wins FDA Approval for Oral Obesity Drug Foundayo
Pharma

Lilly (LLY) Wins FDA Approval for Oral Obesity Drug Foundayo

Apr 1